Making the case for a MedTech AI agent in your 2027 budget: 3 critical questions commercial leaders must answer convincingly
Tips for answering 3 questions you should expect to get from your CFO.
November 16, 2026
You’ve experienced firsthand the value of an AI agent built specifically for MedTech commercial workflows, and now you want your sales reps to use it habitually. To make that happen, you’ll need to sit down with your CFO and request additional budget. As you prepare your business case, make sure you have solid answers to these three critical questions:
- Why do our sales reps need AI in the first place?
- Why do our sales reps need a specialized AI agent? Can’t they just use the same generic chatbot our other employees are already using?
- Why buy an agent when we could just connect our generic chatbot to a data warehouse?
Below is guidance on answering each question.
Question 1: Why do our sales reps need AI in the first place?
Short answer: Because it will help them win more deals. How? By enabling each rep to (1) engage a higher volume of targets and (2) improve their conversion rates through the sales process.
Engaging a higher volume of targets
Research is a fundamental part of MedTech sales; it’s how reps figure out which physicians to prioritize and how to maximize their chances of getting in front of them. The problem with research is that it eats up a lot of time, making it impossible for reps to engage everyone they should.
AI solves this problem. In minutes, it uncovers insights that a rep would need an afternoon to find. Less time spent on research means reps can engage a higher volume of targets (without sacrificing preparation), ultimately translating into a higher volume of opportunities.
Improving conversion rates through the sales process
Oftentimes, when a meeting doesn’t yield or progress an opportunity, it’s because the rep’s talk track wasn’t sufficiently personalized; it wasn’t clear to the physician or administrator how the device would make a meaningful difference.
Again, the problem is capacity. Could the rep have found the insights needed to improve his talk track? Probably. But could he have done it in a reasonable amount of time? Unlikely.
And again, the solution is AI. Personalizing a talk track is easy when AI does the heavy lifting. Higher meeting quality means better conversion rates, ultimately translating into more revenue.
Question 2: Why do our sales reps need a specialized AI agent? Can’t they just use the same generic chatbot our other employees are already using?
Assuming your CFO accepts your answer to Question 1, this question will likely come next. If other teams at your company are already using a generic AI tool like ChatGPT, why wouldn’t your reps use it too?
The short answer is that generic AI tools can’t do what MedTech sales reps need them to do. Again, the whole point of giving reps AI is so they can automate the research that goes into prioritizing targets, figuring out how to get in front of each target, and crafting a talk track personalized to each target. The key to answering this question is helping your CFO understand why generic AI tools are unable to support those use cases.
Take the use case of prioritizing targets. Prioritizing targets requires access to procedure volumes, reimbursement data, and purchase history, none of which are accessible to generic AI tools (see Question 3 for more on the subject of access to data).
Meanwhile, figuring out how to get in front of each target requires intel such as how they split their time between facilities and what their peer network looks like. Again, these are insights far deeper than the surface-level information a rep would get from ChatGPT or Claude.
And when it comes to crafting talk tracks, that requires insight into each physician’s procedure history, volume trends, and patient pathways—details outside the reach of generic AI tools.
In sum, generic AI tools lack the context to support sales reps’ most important use cases.
Question 3: Why buy an agent when we could just connect our generic chatbot to a data warehouse?
Your answer to Question 2 will hopefully be enough to win over your CFO. However, there’s a chance she’ll ask about a data warehouse as a solution to the context problem. Why bring another third-party app into your stack when you could simply buy the relevant data and store it in a warehouse connected to the AI chatbot your company is already using?
The most critical flaw with the data warehouse approach is the lack of an evaluation suite, i.e., a system that assesses the outputs generated by the AI tool and determines whether they meet certain quality standards. Remember: One of the reasons to give reps AI in the first place is so they can ask for recommendations, whether it’s “Which targets should I prioritize next week?” or “How should I approach my meeting with Dr. Alvarez?” In the absence of an evaluation suite, you’ll have no way of knowing whether the AI tool’s recommendations are good or bad.
Another major concern: permissions. If a rep were to prompt ChatGPT with “top ACL surgery providers,” the tool would have no way of knowing what the rep’s territory is, and therefore would have no way of knowing how to produce a useful output. Even worse, the lack of tight permissions means there's a risk of proprietary sales data being exposed to users who aren’t authorized to see it, such as distributors.
And then there’s the matter of cost control. Because generic chatbots like ChatGPT and Claude are not built specifically for MedTech sales workflows, tasks that should be simple (such as generating a call plan or mapping a driving route) can require an extreme amount of work from the tool simply to figure out what the user is asking for. Plus, with generic tools, there’s no way to control costs through model routing, i.e., using a mix of different models to achieve tasks as inexpensively as possible. What all this means for your CFO is that your reps’ AI usage will end up costing a lot more than it should.
Specificity is powerful
Don’t assume that the value of AI for your reps is obvious to your CFO. Be specific about the amount of time reps are spending on research, and what it would mean if they could reallocate that time to meeting with more targets. And if the conversation veers into the data warehouse topic, be ready to explain what that approach would lack: output evaluations, user permissions, and cost controls.
An analogy that might help drive your argument home: A generic chatbot and a MedTech AI agent are both AI, in the same way that a criminal defense lawyer and a real estate lawyer are both lawyers. Would you hire a criminal defense lawyer to help you close on a house?